Imago BioSciences (IMGO) Short Interest Ratio & Short Volume

Short interest is the volume of Imago BioSciences shares that have been sold short but have not yet been closed out or covered. As of December 30th, traders have sold 1,100,000 shares of IMGO short. 5.77% of Imago BioSciences' shares are currently sold short. Learn More on Imago BioSciences' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IMGO shares currently have a short interest ratio of 2.0. Learn More on Imago BioSciences's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.77% of Imago BioSciences' floating shares are currently sold short.

Imago BioSciences saw a increase in short interest during the month of December. As of December 30th, there was short interest totaling 1,100,000 shares, an increase of 10.0% from the previous total of 1,000,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Imago BioSciences currently has issued a total of 33,822,000 shares. Some of Imago BioSciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Imago BioSciences currently has a public float of 19,060,000 shares.

5.77% of Imago BioSciences' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Imago BioSciences: Pacira BioSciences, Inc. (7.42%), Verona Pharma plc (7.51%), Spyre Therapeutics, Inc. (10.55%), Deciphera Pharmaceuticals, Inc. (11.45%), Pieris Pharmaceuticals, Inc. (0.03%), Ligand Pharmaceuticals Incorporated (4.98%), Kiniksa Pharmaceuticals, Ltd. (5.16%), Ironwood Pharmaceuticals, Inc. (13.96%), Xencor, Inc. (10.18%), Collegium Pharmaceutical, Inc. (22.86%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Occidental Petroleum Co. ($3.31 billion), T. Rowe Price Group, Inc. ($2.13 billion), TC Energy Co. ($2.13 billion), Paramount Global ($1.50 billion), Coinbase Global, Inc. ($1.48 billion), Etsy, Inc. ($1.48 billion), PG&E Co. ($1.47 billion), Old Dominion Freight Line, Inc. ($1.46 billion), United Rentals, Inc. ($1.35 billion), and Voya Financial, Inc. ($1.32 billion). View all of the most shorted stocks.

Short selling IMGO is an investing strategy that aims to generate trading profit from Imago BioSciences as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Imago BioSciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of IMGO, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IMGO, twice per month. The most recent reporting period available is December, 30 2022.